MEDGX
Price
$12.54
Change
-$0.01 (-0.08%)
Updated
Oct 6 closing price
Net Assets
7.55B
PAIKX
Price
$9.68
Change
-$0.01 (-0.10%)
Updated
Oct 6 closing price
Net Assets
5.11B
Interact to see
Advertisement

MEDGX vs PAIKX

Header iconMEDGX vs PAIKX Comparison
Open Charts MEDGX vs PAIKXBanner chart's image
MFS Emerging Markets Debt R4
Price$12.54
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
T. Rowe Price Emerging Markets Bond Adv
Price$9.68
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets5.11B
MEDGX vs PAIKX Comparison Chart in %
View a ticker or compare two or three
VS
MEDGX vs. PAIKX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDGX is a Hold and PAIKX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDGX has more cash in the bank: 7.55B vs. PAIKX (5.11B). PAIKX (5.63) and MEDGX (5.50) have matching dividends . MEDGX was incepted earlier than PAIKX: MEDGX (17 years) vs PAIKX (10 years). PAIKX (2.55) is less costly to investors than MEDGX (0.82). MEDGX is a more actively managed with annual turnover of: 58.00 vs. PAIKX (40.20). MEDGX has a lower initial minimum investment than PAIKX: MEDGX (0) vs PAIKX (2500). PAIKX annual gain was more profitable for investors over the last year : 9.07 vs. MEDGX (7.82). PAIKX (14.55) and MEDGX (13.84) have equivalent 5 years return.
MEDGXPAIKXMEDGX / PAIKX
Total Expense Ratio0.811.1570%
Annual Report Gross Expense Ratio0.822.5532%
Fund Existence17 years10 years-
Gain YTD9.19610.60787%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets7.55B5.11B148%
Annual Yield % from dividends5.505.6398%
Returns for 1 year7.829.0786%
Returns for 3 years40.0745.5688%
Returns for 5 years13.8414.5595%
Returns for 10 years49.1238.96126%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLGRX8.990.12
+1.35%
NYLI Winslow Large Cap Growth Class R3
LZSIX13.10N/A
N/A
Lazard International Equity Select Instl
FSSAX27.09N/A
N/A
Franklin Small Cap Growth Adv
DBOYX26.07N/A
N/A
BNY Mellon Balanced Opportunity Y
GSXPX60.88N/A
N/A
Goldman Sachs Small Cp Val Insghts P